Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compounded Anti-Infective Irrigation for Diabetic Foot Ulcers
NCT05076955Phase 1Unknown
- Sponsor
- University of Mississippi Medical Center
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vancomycin, tobramycin and itraconazole in diabetic foot ulcer (DFU), sponsored by University of Mississippi Medical Center. Primary endpoint: Healing Rate at 12 weeks. Status: unknown.
02
Drugs
vancomycintobramycinitraconazole
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT05076955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076955.